Skip to main content
Hester Biosciences Ltd logo

Hester Biosciences Ltd — Investor Relations & Filings

Ticker · HESTERBIO ISIN · INE782E01017 LEI · 984500836B9EB1DC4935 BSE.NS Manufacturing
Open in API
Filings indexed 672 across all filing types
Latest filing 2021-01-30 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS HESTERBIO

About Hester Biosciences Ltd

https://www.hester.in/

Hester Biosciences Ltd specializes in the development, manufacturing, and marketing of animal healthcare products. The company primarily focuses on two segments: poultry healthcare and livestock healthcare. Its extensive product portfolio includes a wide range of live and inactivated vaccines, as well as health products such as therapeutics, herbal supplements, and disinfectants. Hester is recognized for its significant contributions to global animal disease control programs, particularly in the eradication of Peste des Petits Ruminants (PPR) and Brucellosis. The company operates advanced manufacturing facilities and maintains a robust distribution network to serve domestic and international markets. By leveraging research and development, Hester provides diagnostic services and technical support to enhance animal productivity and welfare. Its commitment to quality and innovation has established it as a key provider of biologicals and health solutions for the veterinary sector.

Recent filings

Filing Released Lang Actions
Press Release
Interim / Quarterly Report Classification · 95% confidence The document is a press release dated 30 January 2021 presenting financial highlights for Q3FY21 and 9MFY21, including sales, net profit, EPS, division-wise sales, profitability analysis, and business overviews of various subsidiaries. It contains detailed financial data and analysis for the quarter and nine-month period, including balance sheet ratios and segment performance. The presence of actual financial figures and period-specific performance metrics indicates this is a comprehensive interim financial report rather than a brief earnings release or announcement. The length (7119 characters) and detailed financial content support classification as an Interim / Quarterly Report (IR).
2021-01-30 English
Financial Result Updates
Regulatory Filings
2021-01-30 English
Outcome of Board Meeting
Regulatory Filings
2021-01-30 English
Board Meeting — Financial Results/Fund Raising
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges regarding an addendum to a notice of a Board Meeting scheduled for 30.01.2021. It mentions the Board may consider and approve a proposal for raising funds via equity shares or convertible securities through Qualified Institutional Placement or preferential allotment. It also states that shareholders' approval will be sought through Postal Ballot or other modes. The document is short (1804 characters) and is an announcement about a forthcoming Board Meeting and potential capital raising, not the actual report or detailed financial data. Therefore, it fits the category of Capital/Financing Update (CAP).
2021-01-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a notification addressed to stock exchanges about an upcoming earnings conference call scheduled for January 30, 2021, to discuss the company's unaudited financial results for the quarter and nine months ended December 31, 2020. It includes details about the call, participants, dial-in numbers, and registration links. The document does not contain actual financial statements or detailed financial analysis but serves as an announcement of the earnings call event. Therefore, it fits the category of a Call Transcript (CT) announcement or invitation rather than the transcript itself. However, since the document is specifically an intimation of the earnings conference call, the best fitting category is Call Transcript (CT) as it relates directly to the earnings call event.
2021-01-27 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board Meeting scheduled to consider the unaudited financial results for the quarter and nine months ended 31.12.2020. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, which governs disclosures related to board meetings. The document does not contain any financial data or results itself, only an intimation of the meeting date and agenda. The length is only 1200 characters, indicating it is a brief announcement rather than a full report. Therefore, this is a Board/Management Information filing (MANG) as it relates to a board meeting notice.
2021-01-21 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.